EP3429553A1 - Kit zur kosmetischen behandlung des auges und der haut und kosmetikum zur anwendung am auge und auf der haut - Google Patents

Kit zur kosmetischen behandlung des auges und der haut und kosmetikum zur anwendung am auge und auf der haut

Info

Publication number
EP3429553A1
EP3429553A1 EP17712732.1A EP17712732A EP3429553A1 EP 3429553 A1 EP3429553 A1 EP 3429553A1 EP 17712732 A EP17712732 A EP 17712732A EP 3429553 A1 EP3429553 A1 EP 3429553A1
Authority
EP
European Patent Office
Prior art keywords
cosmetic
eye
weight
solution
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17712732.1A
Other languages
German (de)
English (en)
French (fr)
Inventor
Markus Mahler
Ute Steinfeld
Dominik Holzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ursapharm Arzneimittel GmbH
Original Assignee
Ursapharm Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ursapharm Arzneimittel GmbH filed Critical Ursapharm Arzneimittel GmbH
Publication of EP3429553A1 publication Critical patent/EP3429553A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45DHAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D34/00Containers or accessories specially adapted for handling liquid toiletry or cosmetic substances, e.g. perfumes
    • A45D34/04Appliances specially adapted for applying liquid, e.g. using roller or ball
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45DHAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D44/00Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
    • A45D44/002Masks for cosmetic treatment of the face
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45DHAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00Details not otherwise provided for in A45D
    • A45D2200/10Details of applicators
    • A45D2200/1009Applicators comprising a pad, tissue, sponge, or the like
    • A45D2200/1036Applicators comprising a pad, tissue, sponge, or the like containing a cosmetic substance, e.g. impregnated with liquid or containing a soluble solid substance
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45DHAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00Details not otherwise provided for in A45D
    • A45D2200/15Temperature
    • A45D2200/155Heating or cooling means, i.e. for storing or applying cosmetic products at a predetermined temperature
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45DHAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00Details not otherwise provided for in A45D
    • A45D2200/25Kits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • A61K2800/33Free of surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87Application Devices; Containers; Packaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • A61K2800/884Sequential application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin

Definitions

  • the invention relates to a kit for the topical, cosmetic treatment of the eye and the skin and a cosmetic contained therein for use on the eye and on the skin.
  • Ophthalmic cosmetic formulations known in the art are similar in composition to natural ocular surface film. This means that they contain both watery and oily components. A disadvantage of these already known compositions is frequently that they contain surface-active substances (emulsifiers) in order to be able to ensure permanent dispersion and storage stability.
  • surface-active substances emulsifiers
  • Emulsifiers have an amphiphilic molecular structure consisting of a polar, hydrophilic and a nonpolar, lipophilic moiety, the spatially separated. They lower the interfacial tension between the phases by being located at the interface between both liquids and forming an interfacial film. Stabilization of emulsions is also often used emulsifier mixtures.
  • emulsifiers may be subdivided into ionic (anionic, cationic and amphoteric) and nonionic according to their hydrophilic moiety:
  • anionic emulsifier is soap, commonly referred to as the water-soluble sodium or potassium salts of the saturated and unsaturated higher fatty acids.
  • cationic emulsifiers are quaternary ammonium compounds.
  • the hydrophilic moiety of nonionic emulsifiers often consists of glycerol, polyglycerol, sorbitans, carbohydrates or polyoxyethylene glycols and is usually linked via ester and ether bonds with the lipophilic moiety.
  • emulsifiers can cause allergic reactions in individual cases. Especially with irritated eyes anyway, such additives can lead to incompatibilities and further irritation, because emulsifiers affect the tear film.
  • cosmetic formulations for use on the eye typically also contain preservatives to prevent microbial contamination by bacteria, yeasts and fungi.
  • preservatives Polyquad, Purite and Thiomersal added as a preservative.
  • Further preservatives are also benzoic acid, propionic acid, hexadienoic acid, formaldehyde, inorganic sulfites, 2-phenoxyethanol, benzyl alcohol, hexamethylenetetramine and chloroacetamide.
  • Benzalkonium chloride, benzododecinium chloride and cetrimide reduce the stability of the tear film and cause a dry eye when used for long periods. They attack the cornea of the eye, so that the uppermost layer of the cornea becomes thinner in some places and can cause corneal ulcers. Chlorhexidine, on the other hand, leads to allergic reactions.
  • Skin contains or consists of an aqueous solution, which includes or consists of hyaluronic acid or a salt of hyaluronic acid, salicylic acid or a salt of salicylic acid, sorbitol, Euphrasia mother tincture and a buffer system, wherein no emulsifiers are added to the solution.
  • the cosmetic preferably also contains no preservative, in particular no preservative selected from the group consisting of benzoic acid, propionic acid, hexadienoic acid, formaldehyde, inorganic sulfites, 2-phenoxyethanol, benzyl alcohol, hexamethylenetetramine, chloroacetamide, benzalkonium chloride, benzododecinium chloride,
  • Cetrimide chlorhexidine, chlorobutanol, sodium hydroxymethylglycinate, sodium perborate, phosphonic acid, phenylmercuric acetate, polyhexanide, polyquad, purites, thiomersal, and mixtures thereof.
  • preservative-free cosmetics can be used by contact lens wearers and allergy sufferers throughout the entire pollen season without any concerns.
  • salicylic acid does not fulfill the function of a preservative, but causes the cleaning and care of the eyelids and eye areas and supports the dissolution of adhesions and encrustations on the eye, the resolution of the and also acts locally calming and soothing.
  • phosphates are understood as meaning all phosphate-containing ions, such as, for example, dihydrogen phosphates, hydrogen phosphates, phosphates, but also di-, tri- or metaphosphates.
  • a freedom from phosphate is given when the cosmetic or the underlying solution contains no phosphate ions, d. H. in the cosmetic by means of common analytical
  • Methods can be detected no phosphate ions.
  • the cosmetic is preservative and phosphate-free.
  • the aqueous solution has a pH in the range of 6.0 to 8.0, preferably in the range of 7.0 to 7.2, on.
  • Salicylic acid has an anti-inflammatory and analgesic effect in this concentration.
  • the solution contains sorbitol in a proportion by weight of 1.0 to 4.0% by weight, preferably 2.8% by weight. This is used as an osmoticum and contributes to the isotonicity of the solution.
  • the solution contains Euphrasia mother tincture in a proportion by weight of 0.001 to 0.4% by weight, preferably of 0.3% by weight.
  • Euphrasia mother tincture is a herbal extract.
  • an extract can be obtained from plants or parts thereof, for example using water. Extracts can still be of liquid or solid nature.
  • the Euphrasia mother tincture is obtained from the fresh or dried aerial parts of Euphrasia officinalis such as leaves, flowers and / or stems.
  • extracts of the whole herb of Euphrasia officinalis also referred to as Herba Euphrasiae.
  • Euphrasia eyebright
  • Euphrasia stricta Euphrasia
  • Euphrasia montana Euphrasia rostkoviana
  • mother tincture refers to extracts of plants or parts thereof which are prepared using solvents such as water and / or alcohols such as ethanol, vegetable pressed juices or solutions of dried plants in a solvent mixture such as alcohol-water. Mixture understood.
  • the cosmetic according to the present invention or the underlying solution contains at least one buffer system selected from the group consisting of citrate buffer, borate buffer, phosphate, Tris buffer, trometamol / maleic acid buffer or mixtures or combinations thereof.
  • the cosmetic as above described should preferably be designed phosphate-free, must of course be dispensed with the presence of a phosphate buffer.
  • the cosmetic contains or consists of a buffer system
  • Sodium citrate or a hydrate of the sodium citrate preferably in a proportion by weight of from 0.2 to 1.5% by weight, particularly preferably from 0.5 to 1.0% by weight, in particular of 0.9% by weight,
  • Citric acid preferably in a proportion by weight of 0.002 to 0.008 wt .-%, particularly preferably of 0.002 wt .-% and
  • the solution or the cosmetic does not include a buffer system.
  • a preferred embodiment of the cosmetic comprises a solution containing a sodium salt of hyaluronic acid in a proportion of 0.01 to 1.0 wt .-%, particularly preferably from 0.01 to 0.03 wt .-%, in particular of 0, 02 wt .-%, salicylic acid in a proportion of 0.01 to 2.00 wt .-%, particularly preferably from 0.01 to 0.03 wt .-%, in particular of 0.02 wt .-%, sorbitol in a proportion of 0.5 to 5.0 wt .-%, in particular of 2.80 wt .-%, sodium citrate dihydrate in a proportion of 0.25 to 2.50 wt .-%, in particular of 0.85 wt % and Euphrasia contains mother tincture in a proportion of 0.05 to 1.50 wt .-%, in particular of 0.30 wt .-%, and has a pH of 7.0 to 7.2.
  • the cosmetic or the underlying solution can for example be applied directly to the eyelid for cosmetic purposes, but also indirectly by the cosmetic is applied to a cotton pad or a tissue, and thus the eyelid is moistened or cleaned.
  • the cosmetic eye treatment kit according to the invention comprises the above-described cosmetic and, separately from the cosmetic, at least at least a cotton pad, a tissue and / or an eye mask.
  • the kit is preferably characterized in that the eye mask is heatable and particularly preferably contains a latent heat storage, in particular a sodium acetate trihydrate-containing latent heat storage.
  • the cotton pad, the tissue and / or the eye mask can be designed to receive the cosmetic or the eye mask can be designed to receive the cotton pad.
  • the cosmetic or the solution on which the cosmetic is based can be stored in the above-described kit in a multi-dosing system, a single dosing system or in cosmetic wipes moistened with the cosmetic.
  • a multi-dosing system may comprise, for example, a storage vessel with a pump head, by means of which individual doses of the cosmetic can be dispensed repeatedly.
  • a one-dose system includes a single, separately packaged portion of the cosmetic.
  • the wet wipes can be hygienic and sterile, for example, it can be provided that one or more of the wet wipes are sealed separately in a bag. Thus, easy handling and long durability can be ensured.
  • the wet wipes can be used alone, but also in combination with the aforementioned eye mask and thus also as an alternative to cotton pads.
  • the above-described cosmetic and / or the kit already described above are used according to the invention for the cosmetic treatment of the eye and the skin, in particular for the topical, cosmetic treatment of the skin around the eye area, for the topical, cosmetic treatment of the skin in the area of the eyelid, the upper eyelid , the lower eyelid, the bags, the corner of the eye, the eyelashes, the minor glands, the Zeis glands, the meibomian glands, preferably used for loosening dirt, encrustations, adhesions around the eyes.
  • the cosmetic is preferably applied with the eye closed in the area of the eye area, in particular on the eyelid. It is advantageous if the eyelid is heated to a temperature of 45 ° C.
  • the pads impregnated with the cosmetic or sterile wipes may be placed under the warming eye mask on the closed eyelids or inserted into an eye mask suitable for receiving the pads prior to being placed on the closed eyes.
  • the heat in combination with the nourishing ingredients of the cosmetic cause softening and dissolving the encrustations and adhesions. These can then be easily removed with the pads or wipes to clean the closed eyes.
  • An exemplary cosmetic formed from an aqueous composition containing 0.20 g per liter of the sodium salt of hyaluronic acid, 1.00 g of salicylic acid, 28.00 g of sorbitol, 3.00 g of Euphrasia mother tincture and citric acid and sodium citrate as a buffer system, I'm looking at durability and stability.
  • the pH of this cosmetic was adjusted to 7.0 to 7.2 with sodium hydroxide.
  • the cosmetic contains no emulsifiers and preservatives.
  • Table 1 The composition of this cosmetic is shown in Table 1 below:
  • Samples of this cosmetic were stored at 25 ⁇ 2 ° C and 60 ⁇ 5% relative humidity for a period of 12 months or at 40 ° C and 75% relative humidity for a period of 6 months. Stability and durability are due to different properties of the
  • Cosmetic moored. Decisive are appearance, odor, osmolality, pH value, freedom from particles, viscosity, salicylic acid content, decomposition, conformity of UV-Vis spectra, spray behavior and volume of the aqueous solution.
  • Dosing devices are stored sterile, without a microorganism infestation is to be recorded.
  • TTI Tep Seal Integrity Tests
  • the dosing system is repeatedly actuated overhead while the dropper tip of the dosing system is immersed in a germ suspension containing a high concentration of bacteria (10 7 "colony forming units" per ml).
  • CVIT Closest and Ventilation Integrity Tests
  • Dosing system itself is protected from aerosols from minute spores of germs, even under vacuum conditions.
  • a vacuum is generated in the system during exposure of the dosing system in the wet aerosol, with high density (100 CFU / cm 2 ) to smallest spores.
  • test results presented above show that the cosmetic according to the invention not only has excellent storage stability, but also has a low tendency to bacterial attack.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
EP17712732.1A 2016-03-17 2017-03-17 Kit zur kosmetischen behandlung des auges und der haut und kosmetikum zur anwendung am auge und auf der haut Withdrawn EP3429553A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102016204472.9A DE102016204472A1 (de) 2016-03-17 2016-03-17 Kit zur kosmetischen Behandlung des Auges und der Haut und Kosmetikum zur Anwendung am Auge und auf der Haut
PCT/EP2017/056390 WO2017158157A1 (de) 2016-03-17 2017-03-17 Kit zur kosmetischen behandlung des auges und der haut und kosmetikum zur anwendung am auge und auf der haut

Publications (1)

Publication Number Publication Date
EP3429553A1 true EP3429553A1 (de) 2019-01-23

Family

ID=58398157

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17712732.1A Withdrawn EP3429553A1 (de) 2016-03-17 2017-03-17 Kit zur kosmetischen behandlung des auges und der haut und kosmetikum zur anwendung am auge und auf der haut

Country Status (12)

Country Link
US (1) US20190167542A1 (es)
EP (1) EP3429553A1 (es)
JP (1) JP2019508465A (es)
KR (1) KR20180118676A (es)
CN (1) CN109069382A (es)
AU (1) AU2017235505A1 (es)
BR (1) BR112018068811A2 (es)
CA (1) CA3018000A1 (es)
DE (1) DE102016204472A1 (es)
MX (1) MX2018011250A (es)
RU (1) RU2018132390A (es)
WO (1) WO2017158157A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
JP4818608B2 (ja) * 2002-07-03 2011-11-16 ペリコール・サイエンス・インコーポレーテッド ヒアルロン酸の組成物および使用方法
JP2005139070A (ja) * 2003-11-04 2005-06-02 Kanebo Cosmetics Inc 皮膚化粧料
FR2902290A1 (fr) * 2005-04-28 2007-12-21 Derma Dev Sarl Nouvel agent conservateur anti bacterien et son procede d'obtention
KR20080024426A (ko) * 2006-09-13 2008-03-18 유니메드제약주식회사 히아루론산 유도체의 안정화 조성물
DE102009021372A1 (de) * 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
CA2896646A1 (en) * 2012-12-27 2014-07-03 Hayashibara Co., Ltd. Skin-exterior anti-ageing composition and production method therefor
AT514540A1 (de) * 2013-06-18 2015-01-15 Apomedica Pharmazeutische Produkte Gmbh Ophthalmische Zusammensetzung
DE102014007423A1 (de) * 2014-05-22 2015-11-26 Bitop Ag Zusammensetzung zur Behandlung des Auges

Also Published As

Publication number Publication date
CN109069382A (zh) 2018-12-21
CA3018000A1 (en) 2017-09-21
WO2017158157A1 (de) 2017-09-21
KR20180118676A (ko) 2018-10-31
BR112018068811A2 (pt) 2019-01-22
MX2018011250A (es) 2019-03-28
AU2017235505A1 (en) 2018-10-04
DE102016204472A1 (de) 2017-09-21
RU2018132390A3 (es) 2020-04-17
US20190167542A1 (en) 2019-06-06
JP2019508465A (ja) 2019-03-28
RU2018132390A (ru) 2020-04-17

Similar Documents

Publication Publication Date Title
EP0053754B1 (de) Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
DE69500220T2 (de) Kosmetisches und/oder dermatologisches Mittel aus einem hydrophilen Träger und Vitamin C zum Mischen kurz vor Gebrauch
DE68913239T2 (de) Konservierungszusammensetzung für nasse Wischer.
EP0801948B1 (de) Ophtalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
WO2009056292A1 (de) Osmolythaltige zubereitung zur anwendung bei trockenen schleimhäuten
EP1282446A1 (de) Pharmazeutische und/oder kosmetische zubereitung enthaltend ein organosiloxan und ein phospholipid
EP1762221B1 (de) Insektenabwehrmittel mit Langzeitwirkung
DE60018569T2 (de) Neue Verwendung von hyposmotischen Salzlösungen und darauf basierendes Medikament
WO2019238968A1 (de) Kosmetische zubereitung gegen akne
DE69121405T2 (de) Verfahren zur verminderung der reizenden eigenschaften von kosmetischen zusammensetzungen
US8895080B2 (en) Compositions and kits for ocular treatment
EP1980241B1 (de) Feuchttücher zur Intimpflege für Frauen mit Vitex agnus-castus Extrakt
EP2720757A2 (de) Naturkosmetik-konforme zubereitungen
DE69700111T2 (de) Verwendung von Bernsteinsäureanhydrid-Derivaten in Zusammensetzungen zur Reinigung der Haut
DE69804597T2 (de) Salbe zur behandlung von verbrennungen und anderen hautkrankheiten
EP3429553A1 (de) Kit zur kosmetischen behandlung des auges und der haut und kosmetikum zur anwendung am auge und auf der haut
DE19824681A1 (de) Milben tötendes Reinigungsmittel für Körper und Haare
CH657045A5 (de) Fluessiges desodorierungsmittel.
DE102005030016A1 (de) Hautfreundliches Insektenabwehrmittel
EP1997382B1 (de) Insektenschutzmittel auf Emulsionsbasis
DE2749960B2 (de) Verwendung von Benzylalkohol zur Herstellung reaktivierender kosmetischer Präparate
EP4051217B1 (de) Kosmetische zusammensetzung enthaltend einen extrakt aus opuntia ficus indica
EP0059980A1 (de) Verwendung eines antimikrobiell wirksamen Konservierungsmittels in Ophthalmica und Pflegemitteln für Kontaktlinsen
DE102008053776A1 (de) Additive Pflegeformulierung für Tätowierfarben
WO2000025763A2 (de) Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200401

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200812